Thus, FGF-1 ameliorated insulin resistance both in obesity induced insulin resistance mice, which is associated with its anti-inflammatory action and not through its glucose-lowering activity. Here, FGF1 is linked to obesity due to melanocortin 4 receptor deficiency.